Latest article
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
/cloudfront-us-east-1.images.arcpublishing.com/gray/4MK4HMYRVZBYXKUDVYYKZXHB7Y.PNG "Dickinson County YMCA kicks off health program"){kind=small}
Dickinson County YMCA kicks off health program
IRON MOUNTAIN, me. (WLUC) - With 2021 in the rearview mirror, 2022 promises a new beginning.“After the holidays, everyone usually has a workout...
ACC, Novo Nordisk launch program to enhance sort 2 diabetes care
March 21, 2021
...